Rankings
Pricing
Log In
Free Trial
US-listed companies
Verve Therapeutics, Inc.
Verve Therapeutics, Inc.
VERV
Market cap
$342.99M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Cash and cash equivalents
64
115
Marketable securities
296
439
Collaboration receivable
-
1
Prepaid expenses and other current assets
7
7
Total current assets
367
563
Property and equipment, net
7
19
Restricted cash
5
5
Operating lease right-of-use assets
2
92
Other long term assets
3
1
Total assets
384
679
Accounts payable
7
2
Accrued expenses
13
21
Operating Lease, Liability, Current
2
12
Total current liabilities
22
35
Long-term lease liability
-
70
Deferred revenue, non-current
-
20
Success payment liability
4
3
Other long term liabilities
0
0
Total liabilities
27
128
Common Stock, Value, Issued
0
0
Additional paid-in capital
544
896
Accumulated other comprehensive (loss) income
-0
-1
Accumulated deficit
-187
-344
Total stockholders’ equity (deficit)
357
551
Total liabilities, and stockholders' equity
384
679